| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.009 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |